A B S T R A C T
Background: NUP107 is a novel gene associated with autosomal recessive steroid-resistant nephrotic syndrome (SRNS) with focal segmental glomerulosclerosis (FSGS) in children. The frequency of NUP107 mutations in children with SR-FSGS remains unknown. Methods: Nine families with two siblings affected by childhood-onset SRNS or proteinuria were recruited. FSGS was confirmed by a kidney biopsy in at least one affected sibling in all families. Additionally, 69 sporadic pediatric cases with biopsy-proven SR-FSGS who had not responded to any treatment were included. All coding exons with flanking introns of the NUP107 gene were amplified using polymerase chain reaction and directly sequenced. Results: Biallelic NUP107 mutations were detected in four pairs (44.4%) of siblings from the familial cases and three (4.3%) sporadic cases. All affected patients harbored the p.Asp831Ala mutation in one allele and a truncating or abnormal splicing mutation in the other allele. NUP107 mutation-positive patients showed an earlier onset age (39.4 6 13.1 versus 76.8 6 50.0 months, P¼ 0.027) and more rapid progression to end-stage renal disease (at the ages of 58.9 6 23.4 versus 123.1 6 62.7 months, P<0.001) compared with mutation-negative patients. None of the eight mutation-positive cases, who underwent kidney transplantation, showed recurrence of FSGS in the graft kidney, while 35.3% of mutation-negative cases showed recurrence of FSGS. Conclusions: An unexpectedly high incidence of NUP107 mutations was observed in Korean children with SR-FSGS. Initial genetic screening of children with SR-FSGS should include the NUP107 gene, at least in Korea. Further studies are necessary to determine the incidences of NUP107 mutations in other countries.
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I N T R O D U C T I O N
Most pediatric patients with idiopathic nephrotic syndrome (NS) respond well to steroids. However, 10-20% of the affected children do not respond to oral steroid therapy and are categorized with steroid-resistant nephrotic syndrome (SRNS) [1] [2] [3] [4] . Most children with SRNS have renal pathological lesions of focal segmental glomerulosclerosis (FSGS) and progress to end-stage renal disease (ESRD). To date, mutations in more than 45 genes have been associated with familial and sporadic NS [5] , and $30% of the childhood-onset SRNS cases have a genetic origin [1, [6] [7] [8] [9] . Recently, our group 
reported early-childhood-onset SRNS caused by biallelic mutations in NUP107 in nine individuals from five unrelated families. All affected individuals were Japanese, except for a Korean family with two affected siblings [10] . NUP107 encodes the 107-kDa nucleoporin (NUP107), which is a component of the nuclear pore complex central scaffold, an essential protein in all eukaryotic cells [11, 12] . This present study was conducted to determine the incidence of NUP107 mutations in Korean children with SR-FSGS. We report an unexpectedly high incidence.
M A T E R I A L S A N D M E T H O D S

Patients
In the Genetic Diagnosis Laboratory, Division of Pediatric Nephrology, Department of Pediatrics, Seoul National University Children's Hospital (Seoul, Korea), genomic DNA samples from more than 350 pediatric patients with SRNS have been collected since 2001, including 15 families with possibly dominant inheritance and 13 families with possibly recessive inheritance. In this study, nine pairs of siblings, possibly with recessive inheritance, with genetically undiagnosed SRNS were included. All affected subjects presented with childhood-onset SRNS or proteinuria, except for two index cases who presented with advanced-stage chronic kidney disease. FSGS was confirmed by a kidney biopsy in at least one affected sibling in all families. The clinical features of the four families have been reported previously [13] . In addition, 69 sporadic cases with biopsy-confirmed FSGS were also included, who met the at least one of the two inclusion criteria: (i) progression to ESRD and (ii) no remission with any kind of treatment including initial oral steroids, intravenous pulsed methylprednisolone and calcineurin inhibitors, during the follow-up period of >1 year. Mutational analyses of NPHS1 in all familial cases and NPHS2 and WT1 (exons 8 and 9 only) in all cases revealed no mutations. The study protocol was approved by the institutional review boards of Seoul National University Hospital, Seoul, Korea, and all study samples from the patients and family members were collected after obtaining written informed consent.
Methods
Total genomic DNA was extracted and purified from peripheral leukocytes of all patients and their available family members. All coding exons with flanking introns of NUP107 were amplified using polymerase chain reaction and directly sequenced (primer sequences are available upon request). Cosegregation of the biallelic NUP107 mutations with the phenotype of the family members including both parents were confirmed in all mutation-positive patients.
Quantitative data were described as the mean 6 standard deviation and qualitative data as a frequency (percentage). Quantitative variables were compared using the MannWhitney U test. Chi-square test or Fisher's exact test was used as appropriate to compare proportions between groups. The results were analyzed using SPSS version 22.0 (SPSS, Inc., Chicago, IL, USA). A P-value of <5% was considered statistically significant.
R E S U L T S
Clinical features of the patients Familial cases. All familial cases presented with SRNS, except for two patients presenting with ESRD and two patients with proteinuria, with an average onset age of 52.9 6 48.8 months. All patients, except for one patient presenting with proteinuria, progressed to ESRD at an average age of 83.1 6 76.7 months. Two of the patients died soon after the progression to ESRD (Table 1) .
Sporadic cases. Among the 69 sporadic cases (31 males and 38 females), 51 patients presented with SRNS and 18 presented with proteinuria with/without hematuria. The average onset age was 76.8 6 48.2 months. Forty-six (66.7%) patients progressed to ESRD at an average age of 122.5 6 53.8 months. The remaining 23 patients had persistent SRNS or proteinuria with normal or decreased renal function.
Mutations in NUP107
Mutational analyses revealed five different NUP107 mutations, including three novel mutations (c.1735-3T > G in intron 20, p.Q691*, and p.L225Ffs*15) ( Table 1 ). These novel mutations are not listed in any of the online genomic variation databases, including NHLBI Exome Sequencing Project Exome Variant Server (EVS, http://evs.gs.washington.edu/EVS/), Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org/) and Human Genetics Variation Database, the public exome database of the Japanese population (HGVD, http://www.genome.med.kyoto-u.ac.jp/SnpDB/), or an in-house exome database of 1020 control Koreans subjects. The intron 20 mutation was predicted to lead to splice-site alteration and skipping of exon 21 by in silico software, including NetGene2 (http://www.cbs.dtu.dk/services/NetGene2/), Berkeley Drosophila Genome Project Analysis Tool (http://www.fruitfly. org/seq_tools/other.html) and Alternative Splice Site Predictor (http://wangcomputing.com/assp/index.html), although we did not confirm this through RNA transcription analysis.
Biallelic mutations were detected in 4 pairs (44.4%) of siblings of the familial cases and 3 (4.3%) of the 69 sporadic cases (Figure 1 ). All affected patients had the c.2492A > C (p.Asp831Ala) mutation in one allele and a truncating or abnormal splicing mutation in the other allele. In addition, one sporadic case had a single heterozygous c.2492A > C mutation. The c.1079_1083del (p.Glu360Glyfs*6) mutation was commonly detected, in 6 of 11 affected patients (Table 2) . Two siblings in Family VIII were confirmed to have COQ6 mutations in a later study. Both siblings had sensorineural hearing loss.
Comparison between NUP107 mutation-positive and mutation-negative groups Eleven patients with biallelic NUP107 mutations, including eight familial cases and three sporadic cases, showed an earlier onset age and more frequent and rapid progression to ESRD than the 76 mutation-negative patients (Table 2) (Table 2) .
D I S C U S S I O N
In this study, we found an unexpectedly high incidence of NUP107 mutations in Korean children with SR-FSGS. The incidence in familial cases was 44.4% (4/9) but was 50.0% (5/10) when one previously reported familial case was included (SRNS-12 family in reference [10] ). Furthermore, NUP107 mutations were detected in 4.3% (3/69) of the sporadic cases. All affected patients developed early-onset SRNS or proteinuria at <5 years of age and rapidly progressed to ESRD (19.6 6 21.1 months after onset, range 0-58 months). Notably, all affected individuals in this study and the previous study [10] carried the heterozygous p.Asp831Ala substitution. In the previous study, we confirmed by haplotype analysis that a 412-kb haplotype was shared by all five affected families, suggesting that p.Asp831Ala substitution was derived from an ancestral chromosome or founder effect. In addition, considering the extreme rarity of this mutation in different whole- exome databases, it is likely specific to East Asians, including Japanese and Korean populations. Interestingly, all affected individuals harbored a missense mutation (p.Asp831Ala) in one allele and a truncating or abnormal splicing mutation in the other allele. All subjects showed early-onset disease with rapid progression to ESRD. In contrast, one familial case (SRNS-12 family) in the previous study [10] with a homozygous missense mutation (p.Asp831Ala) showed a later onset in both affected siblings and very mild disease course in one sibling. These findings suggest that some missense NUP107 mutations cause only partial functional impairment. Therefore, screening for NUP107 mutations in SRNS individuals with broad ranges of clinical severity is strongly encouraged.
It remains unknown how NUP107 mutations cause a glomerular phenotype in humans. Nuclear envelope proteins, including nuclear pore complexes, are closely associated with mechano-transduction signaling [14, 15] , and mechanical stretching decreases podocyte proliferation and cell body size by reorganizing the actin cytoskeleton in vitro [16, 17] . Therefore, podocytes with mutant NUP107 may be vulnerable to damage by increased postnatal capillary pressure leading to mechanical cell stretching. The lack of recurrence of FSGS in graft kidneys also supports that the core pathological condition of SRNS caused by NUP107 mutations is a structural abnormality.
NUP107 mutations may cause phenotypes other than SR-FSGS. Recently, a homozygous missense mutation (c.303G > A, p.Met101Ile) was reported in a consanguineous family, and the affected individual presented with global developmental delay, light complexion and early-onset FSGS [18] . Another recent study [19] reported the homozygous c.1339G > A (p.Asp447Asn) mutation in an extended consanguineous family of Palestinian origin; four affected females in the family exhibited XX female gonadal dysgenesis. However, the renal phenotype of these females was not described in the paper [19] . None of our affected individuals with NUP107 recessive mutations showed neurological impairment. In addition, female siblings from Family II are currently of adult age and have normal menstruation cycles, and one (II-1) has a baby. The causes of different phenotypes are currently unknown. Different mutations may cause an additional neurological or ovarian phenotype. Alternatively, additional genetic factors may be involved in neurological or ovarian symptoms of the consanguineous families.
The mutational pattern in children with SRNS in our country differs from that in Western countries, i.e. the incidence of NPHS2 mutations is extremely low, and only one patient with congenital NS was reported to have NPHS2 mutations to date [20, 21] . In contrast, this study revealed an unexpectedly high incidence of NUP107 mutations. Therefore, initial genetic screening of children with SR-FSGS should include NUP107, rather than NPHS2, at least in Koreans. Further studies are necessary to determine the incidence of NUP107 mutations in other countries. 
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